Review



flowcomp release buffer flowcomp flexi kit 11061d  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher flowcomp release buffer flowcomp flexi kit 11061d
    Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
    Flowcomp Release Buffer Flowcomp Flexi Kit 11061d, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/flowcomp+release+buffer/dynabeads+flowcomp+flexi+kit/pmc05928489-190-27-34
    Average 90 stars, based on 1 article reviews
    flowcomp release buffer flowcomp flexi kit 11061d - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Integration of Magnetic Bead-Based Cell Selection into Complex Isolations"

    Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

    Journal: ACS Omega

    doi: 10.1021/acsomega.7b01427

    Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and FlowComp.
    Figure Legend Snippet: Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and FlowComp.

    Techniques Used: Binding Assay, Fluorescence, Generated, Labeling, Standard Deviation

    Characterization of cell capture. (A) Capture of EpCAM-expressing cell lines (Du145 = low, 22Rv1 = medium, LNCaP = high) by each bead type. Beads are abbreviated as follows: SM = Sera-Mag, FC = FlowComp, CELL = CELLection. (B) Nonspecific capture of PBMCs by each bead type across varying PBMC inputs. (C) Direct vs indirect capture of Du145s from a PBMC background. (D) Resultant purity of the captured target cells from direct and indirect capture of Du145s. In all plots, the bars represent the technical replicate average ( n = 3) with error bars representing the standard deviation.
    Figure Legend Snippet: Characterization of cell capture. (A) Capture of EpCAM-expressing cell lines (Du145 = low, 22Rv1 = medium, LNCaP = high) by each bead type. Beads are abbreviated as follows: SM = Sera-Mag, FC = FlowComp, CELL = CELLection. (B) Nonspecific capture of PBMCs by each bead type across varying PBMC inputs. (C) Direct vs indirect capture of Du145s from a PBMC background. (D) Resultant purity of the captured target cells from direct and indirect capture of Du145s. In all plots, the bars represent the technical replicate average ( n = 3) with error bars representing the standard deviation.

    Techniques Used: Expressing, Standard Deviation

    Characterization of the release from FlowComp and CELLection beads. (A,B) Release of a fluorescently labeled anti-EpCAM antibody from (A) FlowComp and (B) CELLection beads. Beads were labeled with low, medium, and high levels of antibody and released for the specified time intervals. (A,B) Dots represent the average of three technical replicates with each technical replicate representing the average of 100 beads (total of 300 beads); error bars represent the standard deviation of the technical replicates. (C) Release of 22Rv1s from FlowComp and CELLection beads across time. (D) Capture efficiency of both FlowComp and CELLection beads when used to capture Du145, 22Rv1, and LNCaP cells. (E) Release efficiency of the three cell lines following bead-based capture. (F) Effective capture following the release of the cells. Gray bars represent the population of cells lost during the release process because of the inefficient release. In each plot, bars represent an average of n = 3; error bars represent the standard deviation.
    Figure Legend Snippet: Characterization of the release from FlowComp and CELLection beads. (A,B) Release of a fluorescently labeled anti-EpCAM antibody from (A) FlowComp and (B) CELLection beads. Beads were labeled with low, medium, and high levels of antibody and released for the specified time intervals. (A,B) Dots represent the average of three technical replicates with each technical replicate representing the average of 100 beads (total of 300 beads); error bars represent the standard deviation of the technical replicates. (C) Release of 22Rv1s from FlowComp and CELLection beads across time. (D) Capture efficiency of both FlowComp and CELLection beads when used to capture Du145, 22Rv1, and LNCaP cells. (E) Release efficiency of the three cell lines following bead-based capture. (F) Effective capture following the release of the cells. Gray bars represent the population of cells lost during the release process because of the inefficient release. In each plot, bars represent an average of n = 3; error bars represent the standard deviation.

    Techniques Used: Labeling, Standard Deviation

    Cell viability following capture and release. (A) The viability of cells (LNCaP, 22Rv1) bound to nonreleaseable beads compared to untouched cells (underwent no magnetic bead isolation) following a 3-day culture (abbreviations: SM = Sera-Mag). (B) The viability of cells bound to (bound) and released from (released) releasable beads (CELLection, FlowComp) following a 3-day culture. Bars represent the average of three technical replicates; error bars represent the standard deviation.
    Figure Legend Snippet: Cell viability following capture and release. (A) The viability of cells (LNCaP, 22Rv1) bound to nonreleaseable beads compared to untouched cells (underwent no magnetic bead isolation) following a 3-day culture (abbreviations: SM = Sera-Mag). (B) The viability of cells bound to (bound) and released from (released) releasable beads (CELLection, FlowComp) following a 3-day culture. Bars represent the average of three technical replicates; error bars represent the standard deviation.

    Techniques Used: Isolation, Standard Deviation

    Characterization of nucleic acid extraction with cell isolation magnetic beads present. (A,B) Relative fold change in the mRNA transcript (HPRT) detected from LNCaPs. Isolations containing cell isolation beads were compared to no-bead controls for two methods of RNA extraction: (A) spin columns and (B) bead-based extraction. (C,D) Similarly, relative fold change in GAPDH from DNA extracted via (C) spins columns or (D) bead-based extraction. Bars represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05 and *** denotes p < 0.001; --- indicates the cell only, no-bead control (abbreviations: CELL = CELLection, SM = Sera-Mag, FC = FlowComp).
    Figure Legend Snippet: Characterization of nucleic acid extraction with cell isolation magnetic beads present. (A,B) Relative fold change in the mRNA transcript (HPRT) detected from LNCaPs. Isolations containing cell isolation beads were compared to no-bead controls for two methods of RNA extraction: (A) spin columns and (B) bead-based extraction. (C,D) Similarly, relative fold change in GAPDH from DNA extracted via (C) spins columns or (D) bead-based extraction. Bars represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05 and *** denotes p < 0.001; --- indicates the cell only, no-bead control (abbreviations: CELL = CELLection, SM = Sera-Mag, FC = FlowComp).

    Techniques Used: Extraction, Cell Isolation, Magnetic Beads, RNA Extraction, Standard Deviation, Control

    Related Articles

    Cell Culture:

    Article Title: Novel Mitochondria-Targeted Asymmetric Heptamethine Cyanine Dye for Cancer Targeted NIR Imaging and Potent Necrosis and Senescence Induction with Prolonged Retention.
    Article Snippet: Developing small molecules that inherently integrate highly tumor-targeted near-infrared fluorescence (NIRF) imaging with potent therapeutic effects remains challenging in anticancer theranostics.. Here, we synthesized and characterized a series of heptamethine cyanine PSs with symmetric and asymmetric structures.. Among them, we first discovered that asymmetric structures significantly enhanced tumor targeting.

    Incubation:

    Article Title: A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer
    Article Snippet: Streptavidin coupled PMPs (Sera-Mag Streptavidin-Blocked SpeedBeads, Cytiva) at a concentration of 50ug per reaction were used for all experiments. .. The PMPs were washed with 0.1%Tween-20 in PBS (0.1%PBST) prior to use then incubated under agitation with 1uL each of capture antibodies against EpCAM (R&D Systems, TROP1), MUC1 (Biolegend, 16A), and TROP2 (R&D Systems, AF650), biotinylated according to the manufacturer’s recommendations (Dynabeads FlowComp Flexi Kit, Thermofisher Scientific ). ..

    Article Title: Magnetic bead-based separation of sperm cells from semen-vaginal fluid mixed stains using an anti-ACRBP antibody.
    Article Snippet: Forensic DNA analysis of semen-vaginal fluid mixed stains is essential and necessary in sexual assault cases.. Here, we used a magnetic bead conjugated acrosin binding protein (ACRBP) antibody to separate and enrich sperm cells from mixed stains.. Previously, western blotting indicated that ACRBP was specifically expressed in sperm cells, but not in female blood and epithelial cells, while immunofluorescence data showed ACRBP was localized to the acrosome in sperm cells.

    Isolation:

    Article Title: Circulating tumor cell enrichment using neoepitopes
    Article Snippet: .. In some embodiments, cells may be isolated using commercially available kits (e.g., Thermo Scientific, at https://tools.thermofisher.com/content/sfs/manuals/dynabeads_flowcompflexi_buffywb_man.pdf), e.g., from ThermoScientific (e.g., Dynabeads Flow Comp Flexi Kit). ..

    other:

    Article Title: Training Australian Dietitians in Behavior Change Techniques Through Educational Workshops: Protocol for a Randomized Controlled Trial.
    Article Snippet: Vaginal mucosal T cells were isolated using Dynabeads® FlowCompTM Flexi Kit (Thermo Fisher Scientific) following the manufacturer's instruction.



    Similar Products

    90
    Thermo Fisher flowcomp release buffer
    Flowcomp Release Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/flowcomp+release+buffer/flowcomp+release+buffer/pmc12173698-280-9-12
    Average 90 stars, based on 1 article reviews
    flowcomp release buffer - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher flowcomp™ release buffer
    Flowcomp™ Release Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/flowcomp+release+buffer/pmc11544820-82-12-15
    Average 90 stars, based on 1 article reviews
    flowcomp™ release buffer - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher flowcomp release buffer flowcomp flexi kit 11061d
    Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
    Flowcomp Release Buffer Flowcomp Flexi Kit 11061d, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/flowcomp+release+buffer/dynabeads+flowcomp+flexi+kit/pmc05928489-190-27-34
    Average 90 stars, based on 1 article reviews
    flowcomp release buffer flowcomp flexi kit 11061d - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher 1 ml of flowcomp release buffer
    Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
    1 Ml Of Flowcomp Release Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/flowcomp+release+buffer/pmc05155722-47-13-16
    Average 90 stars, based on 1 article reviews
    1 ml of flowcomp release buffer - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and FlowComp.

    Journal: ACS Omega

    Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

    doi: 10.1021/acsomega.7b01427

    Figure Lengend Snippet: Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and FlowComp.

    Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

    Techniques: Binding Assay, Fluorescence, Generated, Labeling, Standard Deviation

    Characterization of cell capture. (A) Capture of EpCAM-expressing cell lines (Du145 = low, 22Rv1 = medium, LNCaP = high) by each bead type. Beads are abbreviated as follows: SM = Sera-Mag, FC = FlowComp, CELL = CELLection. (B) Nonspecific capture of PBMCs by each bead type across varying PBMC inputs. (C) Direct vs indirect capture of Du145s from a PBMC background. (D) Resultant purity of the captured target cells from direct and indirect capture of Du145s. In all plots, the bars represent the technical replicate average ( n = 3) with error bars representing the standard deviation.

    Journal: ACS Omega

    Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

    doi: 10.1021/acsomega.7b01427

    Figure Lengend Snippet: Characterization of cell capture. (A) Capture of EpCAM-expressing cell lines (Du145 = low, 22Rv1 = medium, LNCaP = high) by each bead type. Beads are abbreviated as follows: SM = Sera-Mag, FC = FlowComp, CELL = CELLection. (B) Nonspecific capture of PBMCs by each bead type across varying PBMC inputs. (C) Direct vs indirect capture of Du145s from a PBMC background. (D) Resultant purity of the captured target cells from direct and indirect capture of Du145s. In all plots, the bars represent the technical replicate average ( n = 3) with error bars representing the standard deviation.

    Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

    Techniques: Expressing, Standard Deviation

    Characterization of the release from FlowComp and CELLection beads. (A,B) Release of a fluorescently labeled anti-EpCAM antibody from (A) FlowComp and (B) CELLection beads. Beads were labeled with low, medium, and high levels of antibody and released for the specified time intervals. (A,B) Dots represent the average of three technical replicates with each technical replicate representing the average of 100 beads (total of 300 beads); error bars represent the standard deviation of the technical replicates. (C) Release of 22Rv1s from FlowComp and CELLection beads across time. (D) Capture efficiency of both FlowComp and CELLection beads when used to capture Du145, 22Rv1, and LNCaP cells. (E) Release efficiency of the three cell lines following bead-based capture. (F) Effective capture following the release of the cells. Gray bars represent the population of cells lost during the release process because of the inefficient release. In each plot, bars represent an average of n = 3; error bars represent the standard deviation.

    Journal: ACS Omega

    Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

    doi: 10.1021/acsomega.7b01427

    Figure Lengend Snippet: Characterization of the release from FlowComp and CELLection beads. (A,B) Release of a fluorescently labeled anti-EpCAM antibody from (A) FlowComp and (B) CELLection beads. Beads were labeled with low, medium, and high levels of antibody and released for the specified time intervals. (A,B) Dots represent the average of three technical replicates with each technical replicate representing the average of 100 beads (total of 300 beads); error bars represent the standard deviation of the technical replicates. (C) Release of 22Rv1s from FlowComp and CELLection beads across time. (D) Capture efficiency of both FlowComp and CELLection beads when used to capture Du145, 22Rv1, and LNCaP cells. (E) Release efficiency of the three cell lines following bead-based capture. (F) Effective capture following the release of the cells. Gray bars represent the population of cells lost during the release process because of the inefficient release. In each plot, bars represent an average of n = 3; error bars represent the standard deviation.

    Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

    Techniques: Labeling, Standard Deviation

    Cell viability following capture and release. (A) The viability of cells (LNCaP, 22Rv1) bound to nonreleaseable beads compared to untouched cells (underwent no magnetic bead isolation) following a 3-day culture (abbreviations: SM = Sera-Mag). (B) The viability of cells bound to (bound) and released from (released) releasable beads (CELLection, FlowComp) following a 3-day culture. Bars represent the average of three technical replicates; error bars represent the standard deviation.

    Journal: ACS Omega

    Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

    doi: 10.1021/acsomega.7b01427

    Figure Lengend Snippet: Cell viability following capture and release. (A) The viability of cells (LNCaP, 22Rv1) bound to nonreleaseable beads compared to untouched cells (underwent no magnetic bead isolation) following a 3-day culture (abbreviations: SM = Sera-Mag). (B) The viability of cells bound to (bound) and released from (released) releasable beads (CELLection, FlowComp) following a 3-day culture. Bars represent the average of three technical replicates; error bars represent the standard deviation.

    Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

    Techniques: Isolation, Standard Deviation

    Characterization of nucleic acid extraction with cell isolation magnetic beads present. (A,B) Relative fold change in the mRNA transcript (HPRT) detected from LNCaPs. Isolations containing cell isolation beads were compared to no-bead controls for two methods of RNA extraction: (A) spin columns and (B) bead-based extraction. (C,D) Similarly, relative fold change in GAPDH from DNA extracted via (C) spins columns or (D) bead-based extraction. Bars represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05 and *** denotes p < 0.001; --- indicates the cell only, no-bead control (abbreviations: CELL = CELLection, SM = Sera-Mag, FC = FlowComp).

    Journal: ACS Omega

    Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

    doi: 10.1021/acsomega.7b01427

    Figure Lengend Snippet: Characterization of nucleic acid extraction with cell isolation magnetic beads present. (A,B) Relative fold change in the mRNA transcript (HPRT) detected from LNCaPs. Isolations containing cell isolation beads were compared to no-bead controls for two methods of RNA extraction: (A) spin columns and (B) bead-based extraction. (C,D) Similarly, relative fold change in GAPDH from DNA extracted via (C) spins columns or (D) bead-based extraction. Bars represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05 and *** denotes p < 0.001; --- indicates the cell only, no-bead control (abbreviations: CELL = CELLection, SM = Sera-Mag, FC = FlowComp).

    Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

    Techniques: Extraction, Cell Isolation, Magnetic Beads, RNA Extraction, Standard Deviation, Control